These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 8929262
1. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. Mangano DT, Layug EL, Wallace A, Tateo I. N Engl J Med; 1996 Dec 05; 335(23):1713-20. PubMed ID: 8929262 [Abstract] [Full Text] [Related]
2. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C, Diabetic Postoperative Mortality and Morbidity group. Am Heart J; 2004 Apr 05; 147(4):677-83. PubMed ID: 15077084 [Abstract] [Full Text] [Related]
3. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A. Anesthesiology; 2007 Jul 05; 107(1):33-44. PubMed ID: 17585213 [Abstract] [Full Text] [Related]
4. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. N Engl J Med; 1990 Dec 27; 323(26):1781-8. PubMed ID: 2247116 [Abstract] [Full Text] [Related]
5. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Anesth Analg; 2008 Apr 27; 106(4):1039-48, table of contents. PubMed ID: 18349171 [Abstract] [Full Text] [Related]
12. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study]. Ibsen H, Lindholm LH, Pedersen OL, Dahlöf B, Kjeldsen S. Ugeskr Laeger; 2003 Jan 27; 165(5):459-62. PubMed ID: 12599844 [Abstract] [Full Text] [Related]
14. [Postoperative cardiac morbidity/mortality in high-risk elderly patients undergoing non-cardiac surgery]. de la Cruz Pérez C, Estecha Foncea MA, Cruz Mañas J, Castillo Caparrós A, Palma Pérez F, Sarmiento Pardo J. Rev Esp Anestesiol Reanim; 1999 Jan 27; 46(1):4-8. PubMed ID: 10073077 [Abstract] [Full Text] [Related]
15. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Ho T, Taussig D, McAnulty G. N Engl J Med; 1997 May 15; 336(20):1452; author reply 1453-4. PubMed ID: 9148145 [No Abstract] [Full Text] [Related]
19. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB. J Am Coll Cardiol; 2005 Mar 01; 45(5):705-11. PubMed ID: 15734614 [Abstract] [Full Text] [Related]